Video Experimental Relacionado

Updated: Jan 8, 2026

Bidirectional Retroviral Integration Site PCR Methodology and Quantitative Data Analysis Workflow

Bidirectional Retroviral Integration Site PCR Methodology and Quantitative Data Analysis Workflow

Published on: June 14, 2017

Desarrollo de sitios de integración viral evolutivamente conservados como puertos seguros para la terapia génica

Marco A Quezada-Ramírez¹, Matthew A Campbell^2,3, Krishna M Parsi¹

¹Department of Genetic and Cellular Medicine, University of Massachusetts Chan Medical School, Worcester, MA, USA.

|December 24, 2025

Resumen

Los investigadores identificaron nuevos sitios seguros en el genoma (GSH) para una terapia génica más segura. Al analizar la integración de ADN de parvovirus, encontraron sitios en células madre y progenitoras hematopoyéticas (HSPCs) con una interrupción mínima, lo que avanza la adición de genes terapéuticos.

Área de la Ciencia:

Genética
Biología Molecular
Terapia Génica

Sus antecedentes:

La integración de vectores virales para la transferencia de genes en células madre y progenitoras hematopoyéticas (HSPCs) conlleva riesgos como la leucogénesis debido a la mutagénesis insercional.
La identificación de sitios seguros en el genoma (GSH) es crucial para la adición segura de genes terapéuticos, asegurando resultados predecibles.

Objetivo del estudio:

Identificar y caracterizar nuevos candidatos a GSH para la integración génica segura en HSPCs CD34+.
Aprovechar la integración evolutivamente conservada de ADN de parvovirus como método para descubrir GSHs.

Principales métodos:

Se analizaron la preservación de elementos endógenos de parvovirus (EPVs) en diversos genomas de vertebrados.
Se mapearon 102 loci de EPV al genoma humano y se evaluaron experimentalmente 17 como GSHs potenciales en HSPCs CD34+.

Principales resultados:

Se identificaron al menos seis loci adecuados para la inserción de transgenes con baja perturbación del transcriptoma.
Se descubrieron tres loci que exhiben regulación específica de la rama inmune mieloide.
Se generó un catálogo de GSH candidatos para la transgenesis terapéutica.

Conclusiones:

El estudio presenta un enfoque novedoso para identificar GSHs basado en patrones de integración conservados de parvovirus.
Los candidatos a GSH identificados ofrecen potencial para aplicaciones de terapia génica más seguras en HSPCs.
Este trabajo contribuye con recursos valiosos para avanzar en las terapias de adición génica.

Palabras clave:

ingeniería genética genómica investigación de células madre

Más Videos Relacionados

Amplification, Next-generation Sequencing, and Genomic DNA Mapping of Retroviral Integration Sites

Amplification, Next-generation Sequencing, and Genomic DNA Mapping of Retroviral Integration Sites

Published on: March 22, 2016

Lentiviral Vector Platform for the Efficient Delivery of Epigenome-editing Tools into Human Induced Pluripotent Stem Cell-derived Disease Models

Lentiviral Vector Platform for the Efficient Delivery of Epigenome-editing Tools into Human Induced Pluripotent Stem Cell-derived Disease Models

Published on: March 29, 2019

Videos de Conceptos Relacionados

Gene Therapy

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...

Conservative Site-specific Recombination and Phase Variation

Conservative Site-specific Recombination and Phase Variation

Because the DNA segments are cut and reorganized in a direction-specific manner, site-specific recombination has emerged as an efficient genetic engineering technique. Flippase and Cyclization recombinases or Flp and Cre, respectively, are two members of the tyrosine recombinase family derived from bacteriophages, that are used to mediate site-specific DNA insertions, deletions, and targeted expression of proteins in mammalian cell lines.
The recognition sites for Cre recombinase called LoxP...

Viral Mutations

Viral Mutations

A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...

Microorganisms in Medicine and Therapeutics

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.

Size and Structure of Viral Genomes

Size and Structure of Viral Genomes

Viral genomes exhibit remarkable diversity in size, structure, and composition, influencing their replication strategies and interactions with host cells. These genomes consist of either DNA or RNA and may be linear or circular. Additionally, they can be single-stranded or double-stranded, with each configuration affecting how the virus propagates within a host. RNA viruses, for instance, generally have smaller genomes than DNA viruses, a factor that contributes to their high mutation rates and...

Retroviruses

Retroviruses

Retroviruses and retrotransposons both insert copies of their genetic elements into the genome of the host cell. Thus, the viral genes are passed on when the host genome is replicated or translated. A typical retroviral DNA sequence contains 3-4 genes that encode the different proteins required for its structural assembly and function as a molecular parasite. This DNA is transcribed into a single mRNA, which is very similar in structure to conventional mRNAs, i.e., it is capped at the 5’...